StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly U.S. revenue growth YoY by Year

U.S. revenue growth YoY (%) (%)

Eli Lilly U.S. revenue growth YoY: 43.0% in FY2025, up 4.0 pts from a year earlier. That is the highest of the 9 years on record here.

Latest, FY2025
43.0%
Period ended Dec 31, 2025
Change on a year earlier
+4.0 pts
39.0% in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below

Where the FY2025 figure comes from

“|| Percent change | 43 | % | 48 | % | 45 | %”

Source: Form 10-K FY2025 (filed 2026-02-12) ↗

Reported in Form 10-Q / 10-K MD&A Revenue Growth Decomposition Table & Form 8-K Q4 Releases.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. revenue growth YoY (%) (%)Year on yearSource
FY2025Dec 31, 202543.0%+4.0 ptsForm 10-K FY2025 (filed 2026-02-12) ↗
FY2024Dec 31, 202439.0%+19.0 ptsForm 10-K FY2024 (filed 2025-02-19) ↗
FY2023Dec 31, 202320.0%+12.0 ptsForm 10-K FY2023 (filed 2024-02-21) ↗
FY2022Dec 31, 20228.0%-10.0 ptsForm 10-K FY2022 (filed 2023-02-22) ↗
FY2021Dec 31, 202118.0%+6.0 ptsForm 10-K FY2021 (filed 2022-02-23) ↗
FY2020Dec 31, 202012.0%+9.0 ptsForm 10-K FY2020 (filed 2021-02-17) ↗
FY2019Dec 31, 20193.0%-5.0 ptsForm 10-K FY2019 (filed 2020-02-19) ↗
FY2018Dec 31, 20188.0%-3.0 ptsForm 10-K FY2018 (filed 2019-02-19) ↗
FY2017Dec 31, 201711.0%–Form 10-K FY2017 (filed 2018-02-20) ↗

Breakdown

What makes up U.S. revenue growth YoY

Cite this data

StockData. (2026). Eli Lilly U.S. revenue growth YoY (%), annual FY2017–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/rev-growth-us-total

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.